Navigation Links
Alchem International Opens Sales and Marketing Office in the U.S.
Date:2/1/2012

MINNEAPOLIS, February 1, 2012 /PRNewswire/ --

Alchem International Ltd. opens its first North American office in Minneapolis. The sales and marketing office will be spearheaded by Laurent Leduc, former Vice President of Frutarom Health, Inc. This office will cater to the rapidly growing demand in North America for GMP manufacturers of extracts and their purified derivatives for the supplement, pharmaceutical and cosmetic industries.

Alchem International Ltd. is the largest manufacturer of extracts and their purified derivatives in India. Approved by the U.S. FDA, the company has three facilities that comply with international GMP standards. Alchem manufactures herbal extracts and pure pharmaceuticals that conform to USP and other international standards. Its ingredient offerings include natural extracts such as vinpocetine, Coleus Forskolin, sennosides and quinine. Alchem prides itself on its product quality, customer satisfaction and commitment to the environment.

Born in France, Leduc began his international career at Sandoz/Novartis in Minneapolis. In 1995, he led the creation of Acatris Health. Leduc's vast experience includes the release of innovative branded ingredients and proprietary blends.

"I'm very excited about opening Alchem's first North American office and welcome the opportunity to offer to the supplement and cosmetic industries premium quality ingredients and formulations supported by science," says Leduc. "My role will be to introduce the region to Alchem and its portfolio of high-quality ingredients, and to increase service to our customers in North America."

Adds Raman Mehta, CEO of Alchem International, "Our goal is to build long-term supplier relations with manufacturers that, like Alchem, are dedicated to quality and that share our passion to help consumers live a healthy life. Alchem is improving the bioavailability of well-known dietary supplement ingredients, such as silymarin and curcumin, via proprietary technology and is developing new proprietary topical blends for the cosmetics industry."

"We are already seeing an increased demand for our vinpocetine, a new ingredient launch in 2011," continues Leduc. "Vinpocetine is used as a drug for memory enhancement in many countries, and is sold as a dietary supplement in the U.S. Alchem's pharmaceutical-grade vinpocetine is naturally-derived, and is produced in our state-of-the-art facility inspected by the U.S. FDA with zero 493s. Further, it meets European Pharmacopoeia standards."

For further information, please contact:

Laurent Leduc, COO Alchem USA Inc., Tel: +1-952-933-3822, Cell: +1-612-802-6124, laurent@alcheminternational.com

http://www.alcheminternational.com


'/>"/>
SOURCE Alchem International Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. P Summit calls for a new alchemy around phosphorus and food
2. BioRestorative Therapies to Present at 7th International Conference on Cell Therapy for Cardiovascular Disease
3. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
4. Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease
5. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
6. PAREXEL International to Present at J.P. Morgan Healthcare Conference
7. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
8. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
9. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
10. International Attendance for Networking and Education at Informex Beyond Manufacturing
11. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2016)... ... May 17, 2016 , ... DryLet, ... reduction applications, announced today it will be showcasing ManureMagic™ at booth V1061 at ... featured in the Wall Street Journal last year and more recently made news ...
(Date:5/17/2016)... ... May 17, 2016 , ... PATH ... they will collaborate to bring a feeding cup to market based on a ... the Craniofacial Center at Seattle Children’s Hospital, thereby ensuring an innovative feeding option ...
(Date:5/17/2016)... Strekin AG, a start-up ... Switzerland announced today the in-licensing of ... protein kinase.      (Logo: http://photos.prnewswire.com/prnh/20160513/367502LOGO ... the necessary research foundation for the clinical development ... play fundamental roles. Pamapimod has a well-established safety ...
(Date:5/17/2016)... ... 17, 2016 , ... Yukon Medical, a leading developer of ... and Company) to receive its Global Product Innovation Supplier of the Year Award. ... contributions to advancing or supporting key BD initiatives, products, processes, and customer satisfaction. ...
Breaking Biology Technology:
(Date:3/14/2016)... http://www.apimages.com ) - ... - Renvoi : image disponible via AP Images ( ... --> DERMALOG, le leader de l,innovation ... d,empreintes digitales pour l,enregistrement des réfugiés en Allemagne. ... produire des cartes d,identité aux réfugiés. DERMALOG dévoilera ...
(Date:3/10/2016)... Pa. , March 10, 2016   Unisys Corporation ... Customs and Border Protection (CBP) is testing its biometric ... San Diego to help identify certain non-U.S. ... . The test, designed to help determine the efficiency ... environment, began in February and will run until May 2016. ...
(Date:3/8/2016)... 8, 2016   Valencell , the leading ... it has secured $11M in Series D financing. ... new venture fund being launched by UAE-based financial ... existing investors TDF Ventures and WSJ Joshua Fund. ... its triple-digit growth and accelerate its pioneering innovation ...
Breaking Biology News(10 mins):